<?xml version="1.0"?>
<rss version="2.0" xml:base="link" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:media="http://www.rssboard.org/media-rss" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <channel>
    <title>BioMap - South China Morning Post</title>
    <link>https://www.scmp.com/rss/525404/feed</link>
    <description>The latest news, analysis and opinion on BioMap. In-depth analysis, industry insights and expert opinion.</description>
    <language>en</language>
    <image>
      <url>https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png</url>
      <title>BioMap - South China Morning Post</title>
      <link>https://www.scmp.com</link>
    </image>
    <atom:link href="https://www.scmp.com/rss/525404/feed" rel="self" type="application/rss+xml"/>
    <item>
      <author>Themis Qi</author>
      <dc:creator>Themis Qi</dc:creator>
      <description>SmartMore, the first company backed by the Hong Kong government’s investment fund, has applied for a listing, underscoring the city’s crowded pipeline of technology initial public offerings (IPOs).
The unicorn, founded in 2019 and specialising in industrial artificial intelligence, submitted its application on Monday night, with Morgan Stanley, China International Capital Corporation and Deutsche Bank as joint sponsors. SmartMore provides intelligent manufacturing and digital innovation through...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3346854/smartmore-first-firm-backed-hong-kong-wealth-fund-seeks-ipo-tech-pipeline-heats?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3346854/smartmore-first-firm-backed-hong-kong-wealth-fund-seeks-ipo-tech-pipeline-heats?utm_source=rss_feed</link>
      <pubDate>Tue, 17 Mar 2026 06:40:12 +0000</pubDate>
      <title>First HKIC bet SmartMore seeks Hong Kong IPO amid booming tech pipeline</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/17/4c3db1eb-6c4b-4ecc-8b71-0b94e9efd5c5_363ab030.jpg?itok=YNbP_eM6&amp;v=1773728102"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2026/03/17/4c3db1eb-6c4b-4ecc-8b71-0b94e9efd5c5_363ab030.jpg?itok=YNbP_eM6&amp;v=1773728102" width="4095"/>
    </item>
    <item>
      <author>Enoch Yiu</author>
      <dc:creator>Enoch Yiu</dc:creator>
      <description>The success of the government’s Hong Kong Investment Corporation (HKIC) in establishing an ecosystem for start-ups to raise funds has put a damper on the Christmas plans for employees of some local venture capital (VC) firms.
“After partnering with the HKIC, the number of deals we are working on this year has tripled compared to last year,” said David Chang, founder and CEO of leading VC firm MindWorks. He added that 2025 was one of the busiest years for the firm since its establishment 11 years...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3337374/hkic-ends-year-high-note-hong-kong-cost-living-drawback-attracting-talent?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3337374/hkic-ends-year-high-note-hong-kong-cost-living-drawback-attracting-talent?utm_source=rss_feed</link>
      <pubDate>Tue, 23 Dec 2025 02:30:13 +0000</pubDate>
      <title>HKIC ends year on high note but Hong Kong cost of living a drawback for attracting talent</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/12/22/6971a315-d9af-4964-8208-e31aad05a1fb_a14fb313.jpg?itok=IiB0sh1l&amp;v=1766408599"/>
      <media:content height="2846" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/12/22/6971a315-d9af-4964-8208-e31aad05a1fb_a14fb313.jpg?itok=IiB0sh1l&amp;v=1766408599" width="4095"/>
    </item>
    <item>
      <author>Xinmei Shen</author>
      <dc:creator>Xinmei Shen</dc:creator>
      <description>Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government, says it has surpassed Alphabet subsidiary AlphaFold in commercialising artificial intelligence foundation models for drug discovery.
Multinational pharmaceutical companies were seeing a “reverse” in the technological gap between Biomap and AlphaFold, Wei Liu, co-founder and CEO of Biomap and former CEO of Baidu Ventures, said in an interview with the South China Morning...</description>
      <guid isPermaLink="true">https://www.scmp.com/tech/tech-trends/article/3327390/baidu-backed-drug-discovery-start-biomap-challenges-googles-alphafold?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/tech/tech-trends/article/3327390/baidu-backed-drug-discovery-start-biomap-challenges-googles-alphafold?utm_source=rss_feed</link>
      <pubDate>Tue, 30 Sep 2025 23:00:09 +0000</pubDate>
      <title>Baidu-backed drug discovery start-up Biomap challenges Google’s AlphaFold</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/09/30/89b372d8-5db9-4a1d-b1c3-d8727d47ab76_b823869e.jpg?itok=w9Waqc-S&amp;v=1759223024"/>
      <media:content height="2546" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2025/09/30/89b372d8-5db9-4a1d-b1c3-d8727d47ab76_b823869e.jpg?itok=w9Waqc-S&amp;v=1759223024" width="4095"/>
    </item>
    <item>
      <author>Xinmei Shen</author>
      <dc:creator>Xinmei Shen</dc:creator>
      <description>Hong Kong Investment Corporation (HKIC), a HK$62 billion (US$8 billion) government fund, has inked a partnership with Galbot, a Beijing-based humanoid robot start-up, in the latest high-profile move from the financial hub to shore up its artificial intelligence (AI) industry.
The deal will see Galbot establish a local entity called HK-Galbot Embodied AI Lab, and the company will explore applications for humanoid robots in Hong Kong with pilot projects in industries including retail and tourism,...</description>
      <guid isPermaLink="true">https://www.scmp.com/tech/policy/article/3271096/hong-kong-fund-strikes-another-ai-deal-beijing-robot-maker-galbot-boost-industry?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/tech/policy/article/3271096/hong-kong-fund-strikes-another-ai-deal-beijing-robot-maker-galbot-boost-industry?utm_source=rss_feed</link>
      <pubDate>Fri, 19 Jul 2024 09:00:20 +0000</pubDate>
      <title>Hong Kong fund strikes another AI deal with Beijing robot maker Galbot to boost industry</title>
      <enclosure length="4096" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/07/19/92a4f526-b6de-4e19-ad04-50aab1116607_f2e7a856.jpg?itok=VM3bQcIK&amp;v=1721376487"/>
      <media:content height="2732" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/07/19/92a4f526-b6de-4e19-ad04-50aab1116607_f2e7a856.jpg?itok=VM3bQcIK&amp;v=1721376487" width="4096"/>
    </item>
    <item>
      <author>Enoch Yiu</author>
      <dc:creator>Enoch Yiu</dc:creator>
      <description>The government-owned Hong Kong Investment Corporation (HKIC), which manages HK$62 billion (US$8 billion) of funds, has embarked on its investment journey, forming partnerships with key players to foster innovation and technology in the city.
The HKIC on June 24 struck a deal with Beijing-based Biomap – a biotechnology firm launched by Chinese internet giant Baidu’s founder Robin Li Yanhong – to set up an accelerator called BioMap InnoHub to support more than 50 early stage research projects in...</description>
      <guid isPermaLink="true">https://www.scmp.com/business/banking-finance/article/3268312/what-hkic-and-why-it-so-important-hong-kongs-economic-development?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/business/banking-finance/article/3268312/what-hkic-and-why-it-so-important-hong-kongs-economic-development?utm_source=rss_feed</link>
      <pubDate>Fri, 28 Jun 2024 01:30:16 +0000</pubDate>
      <title>What is the HKIC and why is it so important for Hong Kong’s economic development?</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/27/1245ffb9-d343-4387-a7b5-31c40b25fb15_51a84db0.jpg?itok=_2BXmHxl&amp;v=1719485172"/>
      <media:content height="2347" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/27/1245ffb9-d343-4387-a7b5-31c40b25fb15_51a84db0.jpg?itok=_2BXmHxl&amp;v=1719485172" width="4095"/>
    </item>
    <item>
      <author>Olga Wong</author>
      <dc:creator>Olga Wong</dc:creator>
      <description>Hong Kong’s stock market will be more vibrant in the coming months as more substantial initial public offerings (IPOs) are set to be listed in the city, the finance chief has revealed, as he sought to spell out a clearer economic plan for the coming year amid a gloomy outlook.
In an interview with the Post, Financial Secretary Paul Chan Mo-po also said he would visit Australia in September to promote opportunities in the city, and revealed the government’s investment arm was screening more than...</description>
      <guid isPermaLink="true">https://www.scmp.com/news/hong-kong/hong-kong-economy/article/3268331/hong-kong-stock-market-will-rebound-more-ipos-pipeline-second-half-year-paul-chan?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/news/hong-kong/hong-kong-economy/article/3268331/hong-kong-stock-market-will-rebound-more-ipos-pipeline-second-half-year-paul-chan?utm_source=rss_feed</link>
      <pubDate>Fri, 28 Jun 2024 00:30:08 +0000</pubDate>
      <title>Hong Kong stock market will rebound with more IPOs ‘in pipeline’ in second half of year: Paul Chan</title>
      <enclosure length="4095" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/27/385b8733-262d-4614-8c84-56a061f6633c_bb3a1da0.jpg?itok=OCmmVeGU&amp;v=1719491457"/>
      <media:content height="2730" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/27/385b8733-262d-4614-8c84-56a061f6633c_bb3a1da0.jpg?itok=OCmmVeGU&amp;v=1719491457" width="4095"/>
    </item>
    <item>
      <author>Xinmei Shen</author>
      <dc:creator>Xinmei Shen</dc:creator>
      <description>The Hong Kong Investment Corporation (HKIC), a government-owned fund that manages HK$62 billion (US$8 billion) in assets, has struck a deal with a biotechnology firm started by Chinese internet giant Baidu founder Robin Li Yanhong, the fund’s second public move as the city seeks to boost its technology sector.
The partnership will see Beijing-based Biomap set up an accelerator called BioMap InnoHub, which will aim to support over 50 early-stage research and development (R&amp;D) projects in...</description>
      <guid isPermaLink="true">https://www.scmp.com/tech/policy/article/3267756/hong-kongs-us8-billion-government-fund-inks-deal-beijing-biotech-start-city-aims-tech-hub-status?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/tech/policy/article/3267756/hong-kongs-us8-billion-government-fund-inks-deal-beijing-biotech-start-city-aims-tech-hub-status?utm_source=rss_feed</link>
      <pubDate>Mon, 24 Jun 2024 02:51:01 +0000</pubDate>
      <title>Hong Kong’s US$8 billion government fund inks deal with Beijing biotech start-up as city aims for tech hub status</title>
      <enclosure length="1387" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/24/6d5f642f-60d5-4553-9c39-0ace825de371_b97d5929.jpg?itok=_HxeTQuz&amp;v=1719201186"/>
      <media:content height="818" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2024/06/24/6d5f642f-60d5-4553-9c39-0ace825de371_b97d5929.jpg?itok=_HxeTQuz&amp;v=1719201186" width="1387"/>
    </item>
  </channel>
</rss>